However, even with 6 months of anti-TB therapy, only DR-TB decreases the frequency of actCD4+ tmTNF+ and actCD4+ tmTNFR2+ cells, exhibiting a systemic inflammatory status characterised by high levels of TNF, IFN-γ, and IL-12. Here, IFNG is linked to tuberculosis.